Sirolimus Market - Size, Share, and Opportunity
Analysis, 2019-2026.
Sirolimus
is
a
macrolide
compound
also
known
as
rapamycin,
which
is
a
potent
immunosuppressant and shows both antifungal and antineoplastic properties. It works by
weakening the immune system, and helps your body to accept the new organ, so in this
manner it helps in preventing rejection of any organs after transplant. Sirolimus is also used to
coat coronary stents, and prophylaxis of organ transplant rejection in patients receiving renal
transplants, and for treating Lymphangioleiomyomatosis (lung disease).
Request PDF Brochure Of Research Report:
https://www.coherentmarketinsights.com/insight/request-pdf/2842
Global Sirolimus Market Drivers
Approvals for generic versions of Rapamune (a branded sirolimus formulation) for preventing
organ transplant rejection is expected to drive the global sirolimus market growth. For instance,
in January 2019, Novitium Pharma LLC. received the final approval for its abbreviated new
drug application (ANDA) from the U.S. FDA to market a generic version of an oral solution of
Rapamune 1mg/ml manufactured by PF Prism CV. In October 2014, Dr. Reddys Laboratories
Ltd., received the final approval for its abbreviated new drug application (ANDA) from the U.S,
FDA to market a generic version of Rapamune tablet dosage (1mg). Thus, approvals of sirolimus
products by regulatory authorities to manage (or prevent) organ transplant rejection is expected
to drive growth of the global sirolimus market. Factors such as rising incidence of kidney
diseases has led to an increase in the number of kidney transplants. Furthermore, increasing
prevalence of lifestyle-related disorders, improvement of healthcare infrastructure due to
increasing healthcare spending is expected to support global sirolimus market growth over the
forecast period. According to the National Kidney Foundation, in 2014, around 17,107 kidney
transplants took place in the U.S., among which, 5,537 kidneys were from living donors, and
11,570 kidneys were from deceased donors.
Report includes chapters which deeply display the following deliverable about industry :
• Sirolimus Market Research Objective and Assumption